publication date: Mar. 11, 2016
Is Average Sales Price plus 6 percent the right amount to pay doctors under the Medicare Part B program?
Would a smaller margin diminish what may be an incentive for doctors to prescribe the most expensive drugs on the market? With clinical performance being equal, or close enough to equal, is it not better for the doctor’s wallet to bill 6 percent of the highest possible ASP available?
In a move that immediately set off an explosion in the cancer field, the Centers for Medicare and Medicaid Services announced a proposed rule to test new models to improve Part B payment for prescription drugs.
Slamming the Door
Part VII: DePinho’s Stock Tip Revisited
On May 25, 2012, I received an email from Len Zwelling:
Paul: It can’t get worse than having our President pushing his own stock on TV. Len.
I clicked on the provided link to CNBC. What I saw was indeed difficult to process: a video of Ron DePinho, extolling the virtues of the stock of AVEO Pharmaceuticals Inc., a company he co-founded.
National Academy of Medicine Calls for Integrated FDA-CMS Pathway for Biomarker Tests
The National Academy of Medicine listed 10 goals for advancing the appropriate use of biomarker tests in precision medicine.
“How do we ensure patients have timely access to appropriate tests that may accurately direct targeted therapies, while at the same time protecting them from potential harm due to the adoption of poorly validated tests or inappropriately used tests?” the report asked, saying that broader implementation was being held back by a lack of consensus over evidentiary standards, inefficient and inconsistent regulatory and reimbursement approaches, the need for a framework for collecting patient data, and translating that data into improved patient outcomes.
Companies, Health Systems Commit to Data Interoperability
Companies that provide 90 percent of electronic health records used by U.S. health care organizations have agreed to improve the flow of health information for consumers and health care providers, HHS officials said.
Study: California Hospitals with Low Volumes of Surgeries Associated with Higher Risks
In California, nearly 75 percent of the state’s hospitals performed only one or two surgeries when treating one of 11 selected cancer types in 2014, according to a report from the California Health Care Foundation.
The report linked the low hospital surgery volumes with higher rates of mortality and complications, while evaluating cancers of the bladder, brain, breast, colon, esophagus, liver, lung, pancreas, prostate, rectum and stomach.
UNMC Scientist Michael Brattain Dies Unexpectedly at Age 68
Michael Brattain, University of Nebraska Medical Center Eppley Institute professor and associate director for basic research in the Fred & Pamela Buffett Cancer Center, died unexpectedly in his sleep March 5. He was 68.
“Mike was a brilliant scientist who had a prolific scientific career,” said Kenneth Cowan, director of the Eppley Institute and the Buffett Cancer Center. “Mike’s experience and input was extremely valuable to me in many areas within the Buffett Cancer Center.
Sadik Esener to lead OHSU Center for Early Detection Research
Jorge Lopez Jr. Named MSKCC General Counsel
- Aron Parekh receives research grant from American Cancer Society
Robin Mjelle receives grant from Addario Foundation and International Association for the Study of Lung Cancer
William Grady receives grant from DeGregario Family Foundation and the Price Family Foundation
Baylor College of Medicine and Baylor Scott & White Health enter collaboration
Tufts Medical Center and New England Cancer Specialists form affiliation
UC San Francisco and Berkeley Lights Inc. form collaboration
|Drugs and Targets|
FDA Approves Xalkori in NSCLC with ROS-1 mutations
FDA Approves American College of Radiology Digital Mammography QC Manual
Regulatory Authorities in Six Countries approve Yondelis
China Food and Drug Administration Approves CINtec PLUS Cytology Test
Veritas Genetics introduces whole genome platform for under $1,000